share_log

派林生物:派林生物2023年度独立董事述职报告(汪文祺)

Pacific Shuanglin Bio-pharmacy: Pailin Biotech's 2023 Independent Director Debriefing Report (Wang Wenqi)

Sensex a share ·  Apr 26
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more